The Effects of Cardiac Rehabilitation on Mortality and Morbidity in Women: A META-ANALYSIS ATTEMPT : Journal of Cardiopulmonary Rehabilitation and Prevention

Secondary Logo

Journal Logo

Advanced Search
Cardiac Rehabilitation

The Effects of Cardiac Rehabilitation on Mortality and Morbidity in Women

A META-ANALYSIS ATTEMPT

Ghisi, Gabriela Lima de Melo PhD; Chaves, Gabriela Suéllen da Silva PhD; Bennett, Amanda MD; Lavie, Carl J. MD; Grace, Sherry L. PhD, FCCS

Author Information

Cardiovascular Prevention and Rehabilitation Program, Toronto Rehabilitation Institute, University Health Network, University of Toronto, Toronto, Canada (Drs Ghisi and Grace); Physical Therapy Department, Federal University of Minas Gerais, Belo Horizonte, Brazil (Dr Chaves); Division of Cardiology, Department of Medicine, University of Rochester, Rochester, New York (Dr Bennett); Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, Brisbane, Australia (Dr Lavie); and School of Kinesiology and Health Science, York University, Toronto, Canada (Drs Ghisi and Grace).

Correspondence: Sherry L. Grace, PhD, FCCS, York University, Bethune 368, 4700 Keele St, Toronto, ON M3J 1P3, Canada ([email protected]).

The authors declare no conflicts of interest.Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.jcrpjournal.com).

Journal of Cardiopulmonary Rehabilitation and Prevention 39(1):p 39-42, January 2019. | DOI: 10.1097/HCR.0000000000000351

Purpose: 

Cardiac rehabilitation (CR) is associated with significant reductions in mortality and morbidity, but few women are included in trials. Therefore, a meta-analysis of the effects of CR in women is warranted.

Methods: 

Randomized controlled trials from recent systematic reviews that included women attending comprehensive CR and reporting the outcomes of mortality and morbidity (hospitalization, myocardial infarction, bypass surgery, percutaneous coronary intervention) were considered for inclusion. An updated search of the literature was performed from the end date of the last search, based on the Cochrane strategy. Authors were contacted to provide results on women where none were reported.

Results: 

On the basis of 2 recent systematic reviews, 80 trials were identified. Fifty (62.5%) were excluded, most commonly due to lack of inclusion of women (n = 18; 22.5%). One trial was identified through the search update. Of 31 potential trials meeting inclusion criteria, 1 reported results on women and many were old, and hence data by sex were no longer available. Ultimately, data for women were available in 2 trials. Therefore, it was deemed inappropriate to undertake this meta-analysis.

Conclusions: 

This review corroborates the dearth of data on CR in women despite the fact that cardiovascular disease is the leading cause of death in women. Given the totality of evidence, including reductions in mortality and morbidity in nonrandomized studies, and evidence of benefit for other important outcomes such as functional capacity and quality of life, women should continue to be referred to CR.

© 2018 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid